Skip to main content
Loading

New formats / chemical modifications for antisense therapeutics

21 Jun 2024
Salon A
New Modalities
  • In vivo efficacy
  • Safety Issues
  • Biodistribution
  • Tissue/cell-targeted delivery
Industry Expert
Vinod Vathipadiekal, Board Director - Aldebaran Therapeutics